IF‑GLP1 — Accessible Product Page (Demo)
Rx Only

IF‑GLP1 Autoinjector

Once‑weekly GLP‑1 analog to improve glycemic control in adults with type 2 diabetes mellitus (mock demo).

SKU
GLP1‑075‑ENG
Batch
B25‑0901
Volume
3 mL
Strength
0.75 mg/mL
Manufactured
2025‑09‑01
Expires
2027‑09‑01

Grid of product attributes including SKU, batch, volume, strength, manufacture and expiry dates.

Tap "Speak" to hear product details read aloud
Show more product information

Indications

IF‑GLP1 is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Dosage & Administration

Administer subcutaneously once weekly. Rotate injection sites. See full prescribing information for titration guidance.

Warnings

  • Contraindicated with personal/family history of medullary thyroid carcinoma or MEN2.
  • Discontinue if pancreatitis is suspected.
  • Common adverse reactions include nausea, vomiting, and diarrhea.

Ingredients

Active: IF‑GLP1 analog. Inactive: sodium citrate, mannitol, water for injection.

All content mocked for demonstration; not medical advice.